Neurology
Conference Coverage
New fibromyalgia recommendations have firmer evidence base
The new EULAR recommendations for fibromyalgia incorporate a decade’s worth of new evidence collected since the last edition appeared in 2008.
Conference Coverage
Teriflunomide effective for faster-advancing MS
Key clinical point: Teriflunomide is effective for patients with faster-advancing MS. Major finding: Teriflunomide at 14 mg and 7 mg reduced the...
Conference Coverage
Smoking causes worse outcome in MS
Key clinical point: Smoking increases the risk of developing multiple sclerosis and worsens the severity of the disease. Major finding: Regular...
Conference Coverage
LAA occlusion studied for stroke prevention in atrial fib with prior intracerebral hemorrhage
PARIS – Left atrial appendage occlusion appears to be better than medical management for stroke prevention in patients with AF and prior...
News
FDA is investigating Zecuity sumatriptan patch for reports of serious burns
News
Zinbryta approved by FDA for relapsing forms of multiple sclerosis
Conference Coverage
Age, lower baseline ALC increase dimethyl fumarate lymphopenia risk
Key clinical point: Dimethyl fumarate is probably not the best option for older patients with lower baseline lymphocyte counts. Major finding:...
Conference Coverage
Ocrelizumab bests interferon for relapsing MS at 2 years
Key clinical point: Ocrelizumab, a B-cell depleting humanized monoclonal antibody being developed by Hoffman–La Roche, consistently outperformed...
Conference Coverage
Improving our crystal ball: prognostication in neuroscience ICUs
News
Diabetic foot ulcers linked to cognitive decline
Key clinical point: Among patients with type 2 diabetes, those with foot ulcers show cognitive impairment, compared with those who don’t have foot...
Conference Coverage
Screen and treat MS patients for emotional distress, depression
ATLANTA – Nearly half of 2,100 multiple sclerosis patients enrolled at baseline in the Sonya Slifka Longitudinal Multiple Sclerosis Study reported...